Literature DB >> 17713977

Thiopurine treatment in inflammatory bowel disease.

Sharon J Gardiner, Evan J Begg, Ashis Sau, Anthony Marinaki, Richard B Gearry, Murray L Barclay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17713977     DOI： 10.2165/00003088-200746090-00007

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  9 in total

1.  Comment: Breast-feeding during maternal use of azathioprine.

Authors:  Sharon J Gardiner; Richard B Gearry; Rebecca L Roberts; Mei Zhang; Murray L Barclay; Evan J Begg
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

2.  Immunosuppressive therapy and breast-feeding after renal transplantation.

Authors:  D M Grekas; S S Vasiliou; A N Lazarides
Journal:  Nephron       Date:  1984       Impact factor: 2.847

3.  Breast-feeding after renal transplantation.

Authors:  C B Coulam; T P Moyer; N S Jiang; H Zincke
Journal:  Transplant Proc       Date:  1982-09       Impact factor: 1.066

4.  Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs.

Authors:  Sharon J Gardiner; Richard B Gearry; Rebecca L Roberts; Mei Zhang; Murray L Barclay; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

5.  Breast-feeding during treatment with cyclosporine.

Authors:  G Nyberg; U Haljamäe; C Frisenette-Fich; M Wennergren; I Kjellmer
Journal:  Transplantation       Date:  1998-01-27       Impact factor: 4.939

6.  Azathioprine and breastfeeding: is it safe?

Authors:  A Sau; S Clarke; J Bass; A Kaiser; A Marinaki; C Nelson-Piercy
Journal:  BJOG       Date:  2007-01-25       Impact factor: 6.531

7.  Breast-feeding during maternal use of azathioprine.

Authors:  Myla E Moretti; Zul Verjee; Shinya Ito; Gideon Koren
Journal:  Ann Pharmacother       Date:  2006-11-28       Impact factor: 3.154

8.  Breast-feeding by a cyclosporine-treated mother.

Authors:  K D Munoz-Flores-Thiagarajan; T Easterling; C Davis; E F Bond
Journal:  Obstet Gynecol       Date:  2001-05       Impact factor: 7.661

Review 9.  Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.

Authors:  Alexander Teml; Elke Schaeffeler; Klaus R Herrlinger; Ulrich Klotz; Matthias Schwab
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 5.577
  9 in total
  1 in total

Review 1.  Optimising use of thiopurines in inflammatory bowel disease.

Authors:  Lawrence Sunder Raj; A Barney Hawthorne
Journal:  Frontline Gastroenterol       Date:  2010-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.